Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
27 hedge funds and large institutions have $1.56M invested in Histogen Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
4% less funds holding
Funds holding: 28 → 27 (-1)
14% less capital invested
Capital invested by funds: $1.82M → $1.56M (-$261K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$136K |
| 2 |
Renaissance Technologies
New York
|
+$40.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.91K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$8K |
| 4 |
Squarepoint
New York
|
-$6K |
| 5 |
Jane Street
New York
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| $3 | – | – | – |
|
|
BCM
27
Bridgeway Capital Management
Houston,
Texas
| – | -$8K | -98 | Closed |
|
|
28
Squarepoint
New York
| – | -$6K | -81 | Closed |
|
|
29
Jane Street
New York
| – | -$5K | -60 | Closed |
|
30
Group One Trading
Chicago,
Illinois
| – | -$2K | -30 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | +$78 | +1 | New |
|
32
Osaic Holdings
Scottsdale,
Arizona
| – | +$468 | +6 | New |
|
HSTO Hedge Fund Activity: Q1 2020 in Review
27 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2020, worth a combined $1.56M — down 14% from $1.82M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HSTO positions and 5 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $136K. The largest seller was Vanguard Group, cutting an estimated $15K.
- 27 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2020, down from 28 in Q4 2019.
- Funds reported $1.56M of Histogen Inc. Common Stock stock for Q1 2020, down 14% quarter-over-quarter.
- 6 funds opened new Histogen Inc. Common Stock positions in Q1 2020 and 5 closed out, a net change of +1 holder.
- The largest Histogen Inc. Common Stock buyer in Q1 2020 was Acadian Asset Management, an estimated $136K added.
- The largest Histogen Inc. Common Stock seller in Q1 2020 was Vanguard Group, an estimated $15K sold.
Based on aggregated 13F filings for Q1 2020.